Patients taking GLP-1 agonists such as tirzepatide or semaglutide have documented drug interactions
In addition to investigating products with novel molecular targets, the industry is looking toward alternate routes of GLP-1 administration and extended intervals between treatment, among other strategies
The research framework comprised three independent trials with balanced cohort allocations
The convenience of receiving a prescription without having to step into a doctors office has been a game-changer for many
These findings, together with the convenience of oncedaily oral dosing and onceweekly injection, support the use of these medications in this prediabetic population. Karen Elkind-Hirsch Elkind-Hirsch and colleagues recruited 119 premenopausal women aged 18 to 45 years with obesity and PCOS and without diabetes to participate in the study
The upcoming TRIUMPH-Outcomes trial, enrolling 10,000 patients, will eventually provide the kind of multi-year data that transforms confidence in long-term safety